Generics 11

Originals

Biosimilars

Medical devices

Nutraceuticals

Filters

Tirofiban manufacturers

11 products found

Filters

11 products found

tirofiban

Bags for injection/infusion 50 mcg/ml - 250 ml

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP
Unavailable markets
France , Vietnam
Registered in
France
Available for
Distribution only
Manufacturer #15084

Manufacturer usually replies in 18 days

tirofiban

Solution for injection 12.5 mg/50 ml

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
Turkey
GMP approvals
Turkey
Available for
Licensing with supply, Distribution only
Comments
Reference Product : Erbantil
Manufacturer #2748
It is a privately held pharmaceutical company based in southeast Europe that was established in the 1990s to import and introduce pharmaceutical items into medicine. The company began by importing hemophilia and intensive care supplies, as well as immunoglobulin-containing items. To suit market demands, the company has added additional dermatological, cardiological, urological, and surgical goods to its portfolio since then. They now offer a diverse product line that includes not only prescription but also OTC, medical gadgets, and dermo-cosmetics.

Manufacturer usually replies in 7 days

tirofiban

Concentrate for solution for injection 12.5 mg/50 ml

Dossier type
CTD
Dossier status
Ready to file
Country of origin
Turkey
GMP approvals
EU GMP
Manufacturer #2722
It originally entered the pharmaceutical industry in 1987, when it introduced blood derivative products to Europe and became the exclusive distributor for prominent European brands. Oncology, hematology, dermatology, radiology, rheumatology, immunology, and OTC products are the seven main therapeutic fields.

Manufacturer usually replies in 6 days

tirofiban

Concentrate for solution for infusion 12.5 mg/50 ml

Dossier type
CTD
Dossier status
Ready to file
Country of origin
Turkey
GMP approvals
EU GMP
Unavailable markets
Vietnam
Manufacturer #9488
It is a company that has grown up in Europe's pharmaceutical industry, with a product portfolio that includes licensed and contract-manufactured medications. The company is open to collaborating with other local and international companies while carrying out their subcontracting and co-marketing projects. It is dedicated to continuing to add value and work for human health by playing an active role in the local market and around the world. They have more than 30 million in product production.  

Manufacturer usually replies in 5 days

tirofiban

Solution for infusion 12.5mg/50ml

Dossier type
CTD
Dossier status
Ready to file
Country of origin
Turkey
GMP approvals
PICS
Manufacturer #16144
It is a 100% domestically owned and operated pharmaceutical company that was founded in the 2010s. In full conformity with all national and international regulations, the company develops its products in accredited R&D centers and manufactures them in Western Asia with EU-GMP-certified facilities.

Manufacturer usually replies in 2 days

tirofiban

Solution for infusion 50 mcg/ml - 250 ml

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
EU GMP
Unavailable markets
Iran , Vietnam
Available for
Licensing with supply
Comments
Indication: Thrombotic Events; Status: MA granted
Manufacturer #385
A pharmaceutical manufacturer based in the EU that has been active in 60+ countries selling its products in Europe, North America, LATAM, MENA, Africa, and Asia for 60+ years. Key production lines are Rx and nutraceuticals. The company's production lines are EU GMP-compliant.

Manufacturer usually replies in 11 days

tirofiban

Vials, injection 250 mcg/ml - 50 ml

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
EU GMP
Unavailable markets
Iran , Vietnam
Available for
Licensing with supply
Comments
Indication: Thrombotic Events; Status: MA granted
Manufacturer #385
A pharmaceutical manufacturer based in the EU that has been active in 60+ countries selling its products in Europe, North America, LATAM, MENA, Africa, and Asia for 60+ years. Key production lines are Rx and nutraceuticals. The company's production lines are EU GMP-compliant.

Manufacturer usually replies in 11 days

tirofiban

Vials 50 ml, 100 ml

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
GMP, WHO
Manufacturer #24869

Manufacturer usually replies in 3 days

tirofiban

Solution for injection/infusion 12.5 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO
Manufacturer #17147

Manufacturer usually replies in 7 days

tirofiban

Injection 0.25 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
Egypt
GMP approvals
FDA
Manufacturer #21935

Manufacturer usually replies in 35 days

tirofiban

Vials, injection 12.5 mg/50 ml - 50 ml

Dossier type
CTD
Dossier status
Ready to file
Country of origin
Turkey
GMP approvals
PICS
Manufacturer #1430

Manufacturer usually replies in nan days

Tirofiban

Tirofiban is an antiplatelet drug. Tirofiban reduces the frequency of thrombotic cardiovascular events. These events combine endpoint of death, myocardial infarction, or refractory ischemia/repeat the cardiac procedure in patients with non-ST elevation acute coronary syndrome. Its actions prevent blood from clotting during episodes of chest pain or a heart attack, or during procedures related to the blocked coronary artery. It is a non-peptide reversible antagonist of the platelet glycoprotein receptor. It works by inhibiting platelet aggregation. Tirofiban is marketed under the brand name Aggrastat amongst others.  Baxter Healthcare Corporation first filed for a patent of Tirofiban. It was first approved in the US in 2000. Medicare Pharma in the USA markets it.

Forms and Dose:

Tirofiban is available for premixed IV infusion solution in 5mg/100mL and 12.5mg/250mL, and for IV solution vials in 5mg/100mL vialand 3.75mg/15mL bolus vials. In the treatment of Non-ST Elevation Acute Coronary Syndrome, the recommended loading dose is 25 mcg per kilo IV infused within 5 minutes, to reduce the rate of thrombotic cardiovascular events. The post-loading dose is limited to 0.15 mcg per kilo per minute of IV for up to 18 hr. 

The price of Tirofiban:

In the USA, the average price consumers pay for the intravenous solution of 250 mcg/mL is around $68 for a supply of 15 millilitres. However, the price in India for a generic version of this medicine is lower at USD200 for a supply of 50ml. 

How does Tirofiban work?

Tirofiban’s action provide relief by preventing the formation of blood clots during chest pain or heart attack episodes, or while undergoing a procedure related to the blocked coronary artery. Its primary action inhibits platelet aggregation. When administered intravenously, as per the recommended regimen, more than 90% inhibition is attained within 30-minutes of the infusion. 

Finding Tirofiban Manufacturers and Suppliers:

The best way to find and gain access to Tirofiban’s manufacturers and suppliers is to make through Pipelinepharma's global B2B online marketplace for medicines and other pharmaceuticals. In the normal way, finding trusted manufacturers and supplies of specific drugs like Tirofiban can be a time-consuming challenge, but with Pipelinepharma's simple search engine and network of proven partners, the whole process becomes a lot easier. The patient needs to do to get started is to make use of our integrated search engine and start looking for suppliers or manufacturers of this drug to work with and fine-tune his search results using various filters too, letting him search for it from specific countries.